Topic: immunology

close up of a tick insect on a leaf
immunology

New Treatment for Lyme Disease

Tulane researchers have identified a promising new approach to treating persistent neurological symptoms associated with Lyme disease.

illustration of microbial species
immunology

Gut Microbiome May Help HIV Outcomes

Tulane researchers have been awarded a grant to study how changing the gut microbiome may ease gastrointestinal issues for people taking antiretroviral therapy for HIV.

magnifying glass over text focusing on the word Lyme
immunology

Lyme Infection

Tulane researchers found the bacterium that causes Lyme disease in the brain tissue of a woman who had long suffered neurocognitive impairment after her diagnosis and treatment for the tick-borne disease.

photo of Robert Garry in lab
immunology

Coronavirus Detective

Tulane virologist Robert Garry reflects on the COVID-19 pandemic.

photo of Chad Roy in lab
immunology

Virus Survives in Air for Hours

The Tulane National Primate Research Center leads a study on COVID-19 aerosols.

COVID-19 virus illustration above hand framing sunlight in the sky
immunology

The Virus and Vaccines

During the novel coronavirus global pandemic, the Tulane National Primate Research center goes all out to combat COVID-19, an infectious disease like no other.

immunology

Immune Systems

A team of Tulane researchers —James McLachlan, associate professor of microbiology and immunology, John McLachlan, Weatherhead Professor of Pharmacology, and Franck Mauvais-Jarvis, Price-Goldsmith Professor of Nutrition — will study how sex differences shape disparate immune responses in men and women. https://tulane.it/immune-systems

 James McLachlan will lead an immune system study with John McLachlan and Dr. Franck Mauvais-Jarvis
immunology

Tulane receives $1 million to study why women have stronger immune systems

Do women have an extra line of defense in their immune systems that gives them an advantage over men in fighting infections?

immunology

Ricin Treatment

A new study at the Tulane National Primate Research Center showed for the first time that an experimental drug can save nonhuman primates exposed to deadly ricin toxin, a potential bioterrorism agent. http://tulane.it/ricin-treatment